Acute carbohydrate ingestion does not influence the post-exercise iron-regulatory response in elite keto-adapted race walkers.


Journal

Journal of science and medicine in sport
ISSN: 1878-1861
Titre abrégé: J Sci Med Sport
Pays: Australia
ID NLM: 9812598

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 05 11 2018
revised: 11 12 2018
accepted: 29 12 2018
pubmed: 12 1 2019
medline: 14 6 2019
entrez: 12 1 2019
Statut: ppublish

Résumé

Adhering to a low carbohydrate (CHO) high fat (LCHF) diet can alter markers of iron metabolism in endurance athletes. This investigation examined the re-introduction of CHO prior to, and during exercise on the iron-regulatory response to exercise in a homogenous (in regard to serum ferritin concentration) group of athletes adapted to a LCHF diet. Parallel groups design. Three weeks prior to the exercise trials, twenty-three elite race walkers adhered to either a CHO-rich (n=14) or LCHF diet (n=9). A standardised 19-25km race walk was performed while athletes were still adhering to their allocated dietary intervention (Adapt). A second test was performed three days later, where all athletes were placed on a high CHO diet (CHO Restoration). Venous blood samples were collected pre-, post- and 3h post-exercise and measured for interleukin-6 (IL-6) and hepcidin-25. The post-exercise IL-6 increase was greater in LCHF (p<0.001) during both the Adapt (LCHF: 13.1-fold increase; 95% CI: 5.6-23.0, CHO: 8.0-fold increase; 5.1-11.1) and CHO Restoration trials (LCHF: 18.5-fold increase; 10.9-28.9, CHO: 6.3-fold increase; 3.9-9.5); outcomes were not different between trials (p=0.84). Hepcidin-25 concentrations increased 3h post-exercise (p<0.001), however, they did not differ between trials (p=0.46) or diets (p=0.84). The elevated IL-6 response in athletes adapted to a LCHF diet was not attenuated by an acute increase in exogenous CHO availability. Despite diet-induced differences in IL-6 response to exercise, post-exercise hepcidin levels were similar between diets and trials, indicating CHO availability has minimal influence on post-exercise iron metabolism.

Identifiants

pubmed: 30630742
pii: S1440-2440(18)31085-5
doi: 10.1016/j.jsams.2018.12.015
pii:
doi:

Substances chimiques

Dietary Carbohydrates 0
Hepcidins 0
IL6 protein, human 0
Interleukin-6 0
Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

635-640

Informations de copyright

Copyright © 2019 Sports Medicine Australia. All rights reserved.

Auteurs

Alannah K A McKay (AKA)

School of Human Sciences (Exercise and Sport Science), The University of Western Australia, Australia; Australian Institute of Sport, Australia; Western Australian Institute of Sport, Australia. Electronic address: alannah.mckay@ausport.gov.au.

Peter Peeling (P)

School of Human Sciences (Exercise and Sport Science), The University of Western Australia, Australia; Western Australian Institute of Sport, Australia.

David B Pyne (DB)

Australian Institute of Sport, Australia; Research Institute for Sport and Exercise, University of Canberra, Australia.

Marijke Welvaert (M)

Australian Institute of Sport, Australia; Research Institute for Sport and Exercise, University of Canberra, Australia.

Nicolin Tee (N)

Australian Institute of Sport, Australia.

Jill J Leckey (JJ)

Mary MacKillop Institute for Health Research, Australian Catholic University, Australia.

Avish P Sharma (AP)

Australian Institute of Sport, Australia; Research Institute for Sport and Exercise, University of Canberra, Australia.

Megan L R Ross (MLR)

Australian Institute of Sport, Australia; Mary MacKillop Institute for Health Research, Australian Catholic University, Australia.

Laura A Garvican-Lewis (LA)

Australian Institute of Sport, Australia; Mary MacKillop Institute for Health Research, Australian Catholic University, Australia.

Rachel P L van Swelm (RPL)

Department of Laboratory Medicine (TML 830), Radboud University Medical Center, The Netherlands; Hepcidinanalysis.com, The Netherlands.

Coby M Laarakkers (CM)

Department of Laboratory Medicine (TML 830), Radboud University Medical Center, The Netherlands; Hepcidinanalysis.com, The Netherlands.

Louise M Burke (LM)

Australian Institute of Sport, Australia; Mary MacKillop Institute for Health Research, Australian Catholic University, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH